SWINE FLU VACCINE EXPERIMENT - DR R BLAYLOCK



by Dr. Russell Blaylock


Will this vaccine be tested?
According to Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, 5 tests are planned. It is not clear as to the use of the squalene adjuvants, ASO3 and MF-59. Because of concerns raised, the FDA is now hedging. Independent studies of squalene used as a vaccine adjuvant indicates that it is associated with a very high incidence of autoimmune diseases, such as an MS-like neurological syndrome, rheumatoid joint disease and especially Lupus.

The developer of MF-59 is Chiron pharmaceuticals, which was purchased by Novartis pharmaceutical company, who will be the main supplier of the swine flu vaccine for the world. According to Dr. Fauci, testing in both children and adults will be without this adjuvant and he admits that we have no data on the safety in children.(See Nature Vol 460/30 July 2009, p 562 for the interview.)

There are 5 tests scheduled for safety before mass vaccinations will resume. I looked up on clinicaltrials.gov the actual studies being done. It is instructive to note that the only studies actually being done do not contain any adjuvant (the immune booster) either for babies or adults. Yet, when the mass vaccinations begin, the vaccines will have adjuvant added, possibly squalene.

The real irony here is that this is the same bait and switch game they played in the 1976 swine flu vaccine disaster. They tested one vaccine and gave a different one during the mass vaccinations. Here we go again. Over 500 people were paralyzed with Guillain Barre disorder. The incidence was much higher, because it was not a reportable disease. And over 300 people died, which is also a very low figure.

Dr. Fauci admits that they have no idea what will happen when they mix the three viruses from the vaccines together or when they are given sequentially. When he was asked if the results of the studies would be reviewed by the health authorities, he answered, yes, except for those done by the Novartis company. He justified this secrecy by saying that Norvartis had a very advanced testing system, which was done “in-house”—that is, in secrecy.

It is also important to appreciate that this vaccine has been fast-tracked, meaning that many of the usual safety precautions used to prevent contamination of the vaccines will be overlooked by the regulatory agencies. According to a number of studies, vaccine contamination is widespread, with vaccines containing pestivirus, mycoplasma, viral fragments, DNA fragments and bacterial components, all of which can produce chronic systemic disorders, cancer, neurologic diseases and even slow brain degeneration.

Interview with Russell Blaylock, MD: Swine Flu and Compulsory Vaccinations



Part 2

Part 3

Part 4